Page 211 - 2021_12-Haematologica-web

Letters to the Editor
Accepted: August 25, 2021.
Pre-published: September 2, 2021. Disclosures: no conflicts of interest to disclose.
Contributions: MS and BC contributed to the design of the study, analyzed the data, contributed to writing the manuscript and critically reviewed it; MS, MC and CG performed laboratory analyses; TM and SB contributed to microfluidic device production and analysed thrombus formation data; BC and SB consulted on patient manage- ment; PV provided information regarding the negative control; MC and GMP designed the study, coordinated the group, contributed to data analysis and interpretation and wrote and edited the manuscript. All authors read and approved the final manuscript.
Acknowledgments: the authors would like to thank the nursing staff of the Hematology Day Hospital of Presidio San Paolo, ASST Santi Paolo e Carlo, Milan, whose co-operation was essential for the collec- tion of samples for this study; the medical and nursing personnel involved in patient management operating at the Emergency Department of Presidio San Paolo and Presidio San Carlo, Internal Medicine II Division of Presidio San Paolo, and Emergency Medicine of Presidio San Carlo, ASST Santi Paolo e Carlo, Milan, Italy.
Data sharing statement: the raw data that support the findings of this study will be made available by the authors, without undue reser- vation.
References
1.Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov- 19 Vaccination. N Engl J Med. 2021;384(22):2092-2101.
2. Scully M, Singh D, Lown R, et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N Engl J Med. 2021; 384(23):2202-2211.
3. Tiede A, Sachs UJ, Czwalinna A, et al. Prothrombotic immune thrombocytopenia after COVID-19 vaccine. Blood. 2021;138(4):350- 353.
4. Thaler J, Ay C, Gleixner KV, et al. Successful treatment of vaccine- induced prothrombotic immune thrombocytopenia (VIPIT). J Thromb Haemost. 2021;19(7):1819-1822.
5.Vayne C, Rollin J, Gruel Y, et al. PF4 immunoassays in vaccine- induced thrombotic thrombocytopenia. N Engl J Med. 2021; 385(4):376-378.
6. See I, Su JR, Lale A, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021. JAMA. 2021;325(24):2448-2456.
7. Cattaneo M. Thrombosis with thrombocytopenia syndrome associ- ated with viral vector COVID-19 vaccines. Eur J Intern Med. 2021; 89:22-24.
8. American Society of Hematology. Thrombosis with thrombocy- topenia syndrome (also termed vaccine-induced thrombotic throm- bocytopenia). Version 1.4; last updated April 29, 2021. https://www.hematology.org/covid-19/vaccine-induced-immune- thrombotic-thrombocytopenia. Accessed on May 1 , 2021.
9. Sachs UJ, Cooper N, Czwalinna A, et al. PF4-dependent immunoas- says in patients with vaccine-induced immune thrombotic thrombo- cytopenia (VITT): results of an inter-laboratory comparison. Thromb Haemost. 2021 Jun 24. [Epub ahead of print]
10. Mustard JF, Perry DW, Ardlie NG, Packham MA. Preparation of sus- pensions of washed platelets from humans. Br J Haematol. 1972; 22(2):193-204.
11. Morel-Kopp MC, Mullier F, Gkalea V, et al; subcommittee on platelet immunology. Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communica- tion from the SSC of the ISTH. J Thromb Haemost. 2016 Dec;14(12):2548-2552.
12. Scavone M, Bozzi S, Mencarini T, Podda G, Cattaneo M, Redaelli A. Platelet adhesion and thrombus formation in microchannels: the effect of assay-dependent variables. Int J Mol Sci. 2020;21(3):750.
13. Greinacher A, Selleng K, Wesche J, et al. Towards understanding ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombo- cytopenia (VITT). https://www.researchsquare.com/article/rs- 440461/v1. Accessed on April 30, 2021.
14.Uzun G, Althaus K, Singh A, et al. The use of intravenous immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia. Blood. 2021;138(11):992-996.
15. Galeotti C, Kaveri SV, Bayry J. IVIG-mediated effector functions in autoimmune and inflammatory diseases. Int Immunol. 2017; 29(11):491-498.
haematologica | 2021; 106(12)
3231